These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7323533)

  • 1. [Defense and illustration of biological levels].
    Damas J
    Rev Med Liege; 1981 Oct; 36(20):741-5. PubMed ID: 7323533
    [No Abstract]   [Full Text] [Related]  

  • 2. Tiered approach revisited: introducing stage-appropriate or assay-appropriate scientific validation.
    Timmerman P
    Bioanalysis; 2014 Mar; 6(5):599-604. PubMed ID: 24620801
    [No Abstract]   [Full Text] [Related]  

  • 3. Non-targeted screening of drugs.
    Cawley A
    Drug Test Anal; 2021 May; 13(5):892-893. PubMed ID: 33942542
    [No Abstract]   [Full Text] [Related]  

  • 4. Proposal for a harmonized descriptive analyte nomenclature for quantitative large-molecule bioanalysis.
    Heinrich J; Staack RF; Stubenrauch KG; Papadimitriou A
    Bioanalysis; 2015 Dec; 7(24):3057-62. PubMed ID: 26505951
    [No Abstract]   [Full Text] [Related]  

  • 5. Finding time for allosteric interactions.
    Wainer IW
    Nat Biotechnol; 2004 Nov; 22(11):1376-7. PubMed ID: 15529160
    [No Abstract]   [Full Text] [Related]  

  • 6. Impact of matrix-associated soluble factors on the specificity of the immunogenicity assessment.
    Bautista AC; Wullner D; Moxness M; Swanson SJ; Chirmule N; Jawa V
    Bioanalysis; 2010 Apr; 2(4):721-31. PubMed ID: 21083270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Using parallel line assay method based on quantitative responses in methodology evaluation for determining lumbrokinase potency in Rongshuan capsules].
    Dong P; Piao J; Dang A; Wang T; Zhang H; Zhang Z
    Zhongguo Zhong Yao Za Zhi; 2010 Jun; 35(11):1410-4. PubMed ID: 20822009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Supramolecular devices for the high-throughput screening of drugs, nutrients and metabolites in postgenomic era (part 1).
    Bazylak G
    Comb Chem High Throughput Screen; 2007 Jun; 10(5):299-300. PubMed ID: 17896925
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of assay formats for drug-tolerant immunogenicity testing.
    Butterfield AM; Chain JS; Ackermann BL; Konrad RJ
    Bioanalysis; 2010 Dec; 2(12):1961-9. PubMed ID: 21110740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorescence-based liver microsomal assay for screening of pharmaceutical reactive metabolites using a glutathione conjugated 96-well plate.
    Ma X; Chan EC
    Bioconjug Chem; 2010 Jan; 21(1):46-55. PubMed ID: 19957910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug assays in the assessment of the clinical value and safety of new compounds.
    Campbell DB
    Contemp Issues Clin Biochem; 1985; 3():33-60. PubMed ID: 3915972
    [No Abstract]   [Full Text] [Related]  

  • 12. Tracking problems and possible solutions in the quantitative determination of small molecule drugs and metabolites in biological fluids using liquid chromatography-mass spectrometry.
    Bakhtiar R; Majumdar TK
    J Pharmacol Toxicol Methods; 2007; 55(3):262-78. PubMed ID: 17174577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Limulus test for endotoxin (Pyrogen) in radiopharmaceuticals and biologicals.
    Cooper JF; Hochstein HD; Seligmann EB
    Bull Parenter Drug Assoc; 1972; 26(4):153-62. PubMed ID: 5041142
    [No Abstract]   [Full Text] [Related]  

  • 14. Analysis of 75 marketed pharmaceuticals using the GADD45a-GFP 'GreenScreen HC' genotoxicity assay.
    Hastwell PW; Webster TW; Tate M; Billinton N; Lynch AM; Harvey JS; Rees RW; Walmsley RM
    Mutagenesis; 2009 Sep; 24(5):455-63. PubMed ID: 19592503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Availability of plethora of bioanalytical assays for several commonly prescribed drugs - a problem of plenty: perspectives.
    Srinivas NR
    Biomed Chromatogr; 2016 May; 30(5):668-9. PubMed ID: 26892432
    [No Abstract]   [Full Text] [Related]  

  • 16. Correlative microbiological assays.
    Hanka LJ
    Adv Appl Microbiol; 1972; 15():147-56. PubMed ID: 4669833
    [No Abstract]   [Full Text] [Related]  

  • 17. The use of FT-NIR for API content assay in organic solvent media: a single calibration for multiple downstream processing streams.
    Rodrigues LO; Cardoso JP; Menezes JC
    Talanta; 2008 Jun; 75(5):1203-7. PubMed ID: 18585202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual detection approach to a more accurate measure of relative purity in high-throughput characterization of compound collections.
    Lemoff A; Yan B
    J Comb Chem; 2008; 10(5):746-51. PubMed ID: 18698828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of commercial research-grade biomarker assays in drug development: is it time to create 'pharmaceutical-grade' kits?
    Bowsher RR; Nowatzke W; Sailstad JM; Khan MU
    Bioanalysis; 2012 Oct; 4(20):2427-30. PubMed ID: 23157350
    [No Abstract]   [Full Text] [Related]  

  • 20. Cell-based assays in GPCR drug discovery. In this issue.
    Biotechnol J; 2008 Apr; 3(4):430. PubMed ID: 18412181
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.